Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17612290 | 0.86 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL21456900 | 0.82 | LMNA (0.35) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL7057225 | 0.75 | PTGS1 (0.45) | PTGS1PDE4ASLC22A6LMNASLC6A6 | |
| SCHEMBL6831871 | 0.74 | PTGS1 (0.39) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL28788388 | 0.70 | SLC22A6 (0.58) | PTGS1PDE4ASLC22A6LMNASLC6A6 | |
| SCHEMBL18091442 | 0.70 | THRB (0.43) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL10073553 | 0.69 | PTGS1 (0.39) | PTGS1PDE4ASLC22A6LMNASLC6A6 | |
| SCHEMBL2752832 | 0.69 | PTGS1 (0.39) | PTGS1PDE4ASLC22A6LMNASLC6A6 | |
| Ec33 SCHEMBL2310959 | 0.68 | ENPEP (0.59) | PTGS1PDE4ASLC22A6LMNASLC6A6 | |
| Ec33 SCHEMBL1291100 | 0.68 | ENPEP (0.59) | PTGS1PDE4ASLC22A6LMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | PUF60, PHOSPHO1, PLA2G2C | PTGS1 106/4885PDE4A 1523/4885SLC22A6 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.